Alissa K. Robbins

1.6k citations

19 papers · 919 indexed · h-index 12

Molecular Biology
Public Health, Environmental and Occupational Health top 5%
Pulmonary and Respiratory Medicine top 10%
Hematology top 5%
Oncology top 10%

Co-authors: Gavin Halbert David P. Dearnaley Mitch Dowsett Bernard Nutley S.J. Harland Florence I. Raynaud Anne O’Donnell Michael Jarman
Topics: Acute Lymphoblastic Leukemia research (7 papers)Acute Myeloid Leukemia Research (4 papers)Chronic Myeloid Leukemia Treatments (4 papers)
Cited by: Hematology Public Health, Environmental and Occupational Health Oncology
Journals: Proceedings of the National Academy of Sciences Blood PLoS ONE
Partner nations: United States Australia United Kingdom

In The Last Decade

Alissa K. Robbins

18 papers receiving 913 citations

Peers

Countries citing papers authored by Alissa K. Robbins

Since Specialization

Citations

This map shows the geographic impact of Alissa K. Robbins's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alissa K. Robbins with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alissa K. Robbins more than expected).

Fields of papers citing papers by Alissa K. Robbins

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alissa K. Robbins. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alissa K. Robbins. The network helps show where Alissa K. Robbins may publish in the future.

Co-authorship network of co-authors of Alissa K. Robbins

This figure shows the co-authorship network connecting the top 25 collaborators of Alissa K. Robbins. A scholar is included among the top collaborators of Alissa K. Robbins based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alissa K. Robbins. Alissa K. Robbins is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

#	Work	Indexed citations
1	Goal alignment and unintended consequences of accountable care: How the structure of Oregon’s Medicaid coordinated care model shapes health plan–clinic partnerships 2025 ·Journal of Clinical and Translational Science ·Erin S. Kenzie,(unknown),(unknown),(unknown),Alissa K. Robbins,Melinda M. Davis	0
2	Improving screening, brief intervention and referral to treatment for unhealthy alcohol use in diverse, low-resourced primary care clinics 2024 ·BMC Health Services Research ·Melinda M. Davis,(unknown),Victoria A. Sanchez,Erin S. Kenzie,(unknown),(unknown),(unknown),(unknown),(unknown),Alissa K. Robbins,(unknown),Brigit Hatch	3
3	Improving screening, treatment, and intervention for unhealthy alcohol use in primary care through clinic, practice-based research network, and health plan partnerships: Protocol of the ANTECEDENT study 2022 ·PLoS ONE ·(unknown),Victoria A. Sanchez,Erin S. Kenzie,(unknown),(unknown),(unknown),Alissa K. Robbins,(unknown),Brigit Hatch,(unknown),Nancy Elder,John Muench,Melinda M. Davis	6
4	PD-1 cooperates with AIRE-mediated tolerance to prevent lethal autoimmune disease 2022 ·Proceedings of the National Academy of Sciences ·Antonia N. Policheni,Charis E. Teh,Alissa K. Robbins,Selma Tuzlak,Andreas Strasser,Daniel H.D. Gray	13
5	Caspase-8 has dual roles in regulatory T cell homeostasis balancing immunity to infection and collateral inflammatory damage 2022 ·Science Immunology ·Charis E. Teh,Simon Preston,Alissa K. Robbins,Michael D. Stutz,James P. Cooney,Michelle P. Clark,Antonia N. Policheni,Cody C. Allison,Liana Mackiewicz,Philip Arandjelovic,Gregor Ebert,Marcel Doerflinger,Tania Tan,Lucille C. Rankin,Peggy P. Teh,Gabrielle T. Belz,Axel Kallies,Andreas Strasser,Marc Pellegrini,Daniel H.D. Gray	15
6	MCL-1 is essential for survival but dispensable for metabolic fitness of FOXP3+ regulatory T cells 2020 ·Cell Death and Differentiation ·Charis E. Teh,Alissa K. Robbins,Darren C. Henstridge,Grant Dewson,Sarah T. Diepstraten,Gemma L. Kelly,Mark A. Febbraio,Sarah S. Gabriel,Lorraine A. O’Reilly,Andreas Strasser,Daniel H.D. Gray	2
7	Rare Inherited Defects of the Complement System in Purpura Fulminans 2020 ·Blood ·Pavan K. Bendapudi,(unknown),Onuralp Söylemez,(unknown),Meaghan Colling,(unknown),Alissa K. Robbins,(unknown),(unknown),Sanjay Ram,Ágnes Tóth-Petróczy,Joel B. Krier,Elizabeth L. Fieg,Sunny Dzik,(unknown),Olga Pozdnyakova,Valentina Nardi,Richard L. Maas,Julie-Aurore Losman	2
8	Autochthonous tumors driven by Rb1 loss have an ongoing requirement for the RBP2 histone demethylase 2018 ·Proceedings of the National Academy of Sciences ·Samuel K. McBrayer,Benjamin A. Olenchock,(unknown),Diana D. Shi,Januka Khanal,Rebecca B. Jennings,Jesse Novak,Matthew G. Oser,Alissa K. Robbins,(unknown),Dennis M. Bonal,Javid J. Moslehi,Roderick T. Bronson,Donna Neuberg,Quang-Dé Nguyen,Sabina Signoretti,(unknown),William G. Kaelin	12
9	Persistence of endothelial thrombomodulin in a patient with infectious purpura fulminans treated with protein C concentrate 2018 ·Blood Advances ·Pavan K. Bendapudi,Alissa K. Robbins,Nicole R. LeBoeuf,Olga Pozdnyakova,Ami S. Bhatt,Fujiko Duke,(unknown),John R. McQuiston,Ben W. Humrighouse,(unknown),Meaghan Colling,Kathryn E. Stephenson,Arturo P. Saavedra,Julie-Aurore Losman	10
10	Acute Sensitivity of Ph-like Acute Lymphoblastic Leukemia to the SMAC-Mimetic Birinapant 2016 ·Cancer Research ·Jennifer Richmond,Alissa K. Robbins,Kathryn Evans,Dominik Beck,Raushan T. Kurmasheva,Catherine A. Billups,Hernán Carol,Susan L. Heatley,Rosemary Sutton,Glenn M. Marshall,Deborah L. White,John E. Pimanda,Peter J. Houghton,Malcolm A. Smith,Richard B. Lock	18
11	Quantitative Phosphotyrosine Profiling of Patient-Derived Xenografts Identifies Therapeutic Targets in Pediatric Leukemia 2016 ·Cancer Research ·Sibasish Dolai,(unknown),Alissa K. Robbins,Ling Zhong,Susan L. Heatley,Tiffaney L. Vincent,Falko Hochgräfe,Rosemary Sutton,Raushan T. Kurmasheva,Tamás Révész,Deborah L. White,Peter J. Houghton,Malcolm A. Smith,David T. Teachey,Roger J. Daly,Mark J. Raftery,Richard B. Lock	12
12	Venetoclax responses of pediatric ALL xenografts reveal sensitivity of MLL-rearranged leukemia 2016 ·Blood ·Seong Lin Khaw,Santi Suryani,Kathryn Evans,Jennifer Richmond,Alissa K. Robbins,Raushan T. Kurmasheva,Catherine A. Billups,Stephen W. Erickson,Yuelong Guo,Peter J. Houghton,Malcolm A. Smith,Hernán Carol,Andrew W. Roberts,David C.S. Huang,Richard B. Lock	112
13	Synergism of FAK and tyrosine kinase inhibition in Ph+ B-ALL 2016 ·JCI Insight ·Michelle L. Churchman,Kathryn Evans,Jennifer Richmond,Alissa K. Robbins,(unknown),Irina M. Shapiro,Jonathan A. Pachter,David T. Weaver,Peter J. Houghton,Malcolm A. Smith,Richard B. Lock,Charles G. Mullighan	44
14	Effective Targeting of the P53–MDM2 Axis in Preclinical Models of Infant MLL -Rearranged Acute Lymphoblastic Leukemia 2015 ·Clinical Cancer Research ·Jennifer Richmond,Hernán Carol,Kathryn Evans,(unknown),(unknown),Alissa K. Robbins,Claus Meyer,Nicola C. Venn,Rolf Marschalek,Michelle J. Henderson,Rosemary Sutton,Raushan T. Kurmasheva,Ursula R. Kees,Peter J. Houghton,Malcolm A. Smith,Richard B. Lock	41
15	Efficacy of JAK/STAT pathway inhibition in murine xenograft models of early T-cell precursor (ETP) acute lymphoblastic leukemia 2015 ·Blood ·Shannon L. Maude,Sibasish Dolai,Cristina Delgado-Martín,Tiffaney L. Vincent,Alissa K. Robbins,Arthavan Selvanathan,Theresa Ryan,Junior Hall,Andrew Wood,Sarah K. Tasian,Stephen P. Hunger,Mignon L. Loh,Charles G. Mullighan,Brent L. Wood,Michelle L. Hermiston,Stephan A. Grupp,Richard B. Lock,David T. Teachey	158
16	Abstract 3276: Evaluation of the Bcl-2 inhibitor ABT-199 in xenograft models of acute lymphoblastic leukemia by the pediatric preclinical testing program 2015 ·Cancer Research ·Santi Suryani,Kathryn Evans,Jennifer Richmond,Alissa K. Robbins,(unknown),Raushan T. Kurmasheva,Peter J. Houghton,Malcolm A. Smith,Richard B. Lock	3
17	Hormonal impact of the 17α-hydroxylase/C17,20-lyase inhibitor abiraterone acetate (CB7630) in patients with prostate cancer 2004 ·British Journal of Cancer ·Anne O’Donnell,Ian Judson,Mitch Dowsett,Florence I. Raynaud,David P. Dearnaley,M. Mason,S.J. Harland,Alissa K. Robbins,Gavin Halbert,Bernard Nutley,Michael Jarman	300
18	A phase I trial of antibody directed enzyme prodrug therapy (ADEPT) in patients with advanced colorectal carcinoma or other CEA producing tumours 2002 ·British Journal of Cancer ·Roslyn J. Francis,Sanjay Sharma,Caroline J. Springer,(unknown),Laura Hope‐Stone,Laura A. Sena,Janet Martin,Kathryn Adamson,Alissa K. Robbins,Lindsey Gumbrell,David M. O’Malley,(unknown),(unknown),(unknown),Daniel Hochhauser,A. J.W. Hilson,D C Blakey,Richard H. J. Beǵent	109
19	A phase II trial of bryostatin 1 in patients with non-Hodgkin's lymphoma 2001 ·British Journal of Cancer ·Fiona Blackhall,Malcolm Ranson,John Radford,Barry W. Hancock,M Soukop,Andrew McGown,Alissa K. Robbins,Gavin Halbert	59

About Alissa K. Robbins

Alissa K. Robbins is a scholar working on Hematology, Geriatrics and Gerontology and Public Health, Environmental and Occupational Health, having authored 19 papers that have together received 919 indexed citations. Recurring topics across this work include Acute Lymphoblastic Leukemia research (7 papers), Acute Myeloid Leukemia Research (4 papers) and Chronic Myeloid Leukemia Treatments (4 papers). The work is most often cited by research in Hematology (242 citations), Public Health, Environmental and Occupational Health (272 citations) and Oncology (239 citations). Alissa K. Robbins has collaborated with scholars based in United States, Australia and United Kingdom. Frequent co-authors include Gavin Halbert, David P. Dearnaley, Mitch Dowsett, Bernard Nutley, S.J. Harland, Florence I. Raynaud, Anne O’Donnell, Michael Jarman, M. Mason and Ian Judson. Their work appears in journals such as Proceedings of the National Academy of Sciences, Blood and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact